VeriMom¿Es calcium sodium fluorophosphosilicate seguro durante el embarazo?
No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments flag reproductive hazard for calcium sodium fluorophosphosilicate; peer‑reviewed literature does not indicate developmental/teratogenic effects from topical cosmetic exposure. The material is an insoluble inorganic glass with low dermal bioavailability under normal topical use, so hazard and mechanism scores remain 0. Sources searched: ECHA Annex VI (no harmonised classification), CIR (no safety restriction), PubMed (no reproductive signals).
Related ingredients
Frequently asked questions
- ¿Es calcium sodium fluorophosphosilicate seguro durante el embarazo?
- No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR safety assessments flag reproductive hazard for calcium sodium fluorophosphosilicate; peer‑reviewed literature does not indicate developmental/teratogenic effects from topical cosmetic exposure. The material is an insoluble inorganic glass with low dermal bioavailability under normal topical use, so hazard and mechanism scores remain 0. Sources searched: ECHA Annex VI (no harmonised classification), CIR (no safety restriction), PubMed (no reproductive signals).
- ¿Es calcium sodium fluorophosphosilicate seguro durante la lactancia?
- Same rationale as for pregnancy: no regulatory harmonised reproductive classification or published evidence of lactation transfer or milk toxicity from topical use. Low expected dermal/systemic absorption from an insoluble glass limits exposure to breastmilk. Sources: ECHA Annex VI, CIR, PubMed, CosIng/PubChem summary data (no reproductive flags).
- ¿Es calcium sodium fluorophosphosilicate seguro para la piel del bebé?
- No evidence of reproductive or mechanistic concern in infants. However, neonatal/infant skin barrier is less mature so dermal exposure potential is higher; although the parent material is an insoluble glass with low systemic uptake, per scoring rules exposure for 0–3 yr is increased by +1 relative to adults. No infant‑specific adverse data found in PubMed or regulatory databases. Sources: PubMed, ECHA/CosIng/PubChem summaries (no infant-specific toxicity).
- ¿Cómo puntúa VeriMom a calcium sodium fluorophosphosilicate?
- VeriMom puntúa calcium sodium fluorophosphosilicate en 100/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a calcium sodium fluorophosphosilicate en el embarazo?
- Consulta nuestra lista de alternativas seguras a calcium sodium fluorophosphosilicate según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.